Hydromorphone vs Nivolumab
Hydromorphone vs Nivolumab: Overview
This comparison examines the pharmacological differences between Hydromorphone and Nivolumab.
Mechanism of Action
Hydromorphone: Semisynthetic mu-opioid receptor agonist approximately 5 times more potent than morphine.
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Pharmacokinetics
Half-life: Hydromorphone — 2-3 hours; Nivolumab — 27 days.
Chemical Properties
Molecular Formula: Hydromorphone — C17H19NO3.
Molecular Weight: Hydromorphone — 285.3380 g/mol.
Type: Hydromorphone — Small molecule; Nivolumab — Antibody.